3P Biopharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has appointed Iker Portugal as chief financial officer.   Portugal is an experienced financial manager and joins 3P Biopharmaceuticals with the aim of boosting the company´s growth plans. With this new addition to the management team, 3P Biopharmaceuticals continues its growth plan and consolidates a competitive position as one of the leading...